A Study to Learn If the Study Medicine Called Vepdegestrant Changes How the Body Processes the Other Study Medicine Called Midazolam

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-508518-40-00

Enrollment

Registered

2024-01-31

Start date

2024-02-05

Completion date

2024-05-13

Last updated

2024-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ER+/HER2 positive breast cancer

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium

None listed

Source: EU CTIS · Data processed: Feb 4, 2026